Blue Belt Technologies, Inc. Secures $40 Million

2014-10-31
合作
Blue Belt Technologies Closes $40 Million in Debt Financing from CRG MINNEAPOLIS--(BUSINESS WIRE)--Blue Belt Technologies, Inc. and CR Group (“CRG”) announced that they have closed a senior secured term loan for up to $40 million of capital. Blue Belt Technologies is an orthopaedic surgical technology company with a focus on commercializing the next generation of robotic-assisted surgical tools. The company’s flagship product, the Navio® Surgical System, received CE Mark and FDA 510(k) clearance in 2012 and has been commercial in the U.S. since February, 2013. The Navio system provides robotic-assistance for partial knee replacement procedures through proprietary CT-free navigation software and a unique hand held computer controlled bone shaping tool. “Blue Belt Technologies represented a unique and compelling investment opportunity for CRG. We were impressed with the company's track record that showed a history of completing important milestones on time and on budget. Over the past few months, Blue Belt has executed co-marketing agreements with major players in the space (with more expected to follow), expanded its bench strength, released a new application and has significantly progressed in the development of new applications that fulfill unmet clinical needs in orthopedics. We are pleased to provide Blue Belt with capital to invest in long term growth and continue the momentum that they have established,” said Charles Tate, Chairman of CRG. “We could not be more pleased to partner with the team at CRG. Our ability to continue our established momentum, grow our commercial footprint and expand our technology platform across multiple specialties will be fueled by this CRG investment. Our focus remains on improving patient outcomes by delivering robotic assisted solutions for underserved clinical needs,” said Eric B. Timko, President and CEO of Blue Belt Technologies. “Further, this capital will enable us to deepen our collaborations with strategic partners across business and technology initiatives.” Blue Belt Technologies, Inc. Blue Belt Technologies, Inc. is developing the next generation of “smart” surgical instruments for initial use in orthopedic procedures and then for other surgical specialties including neurosurgery, spinal and otolaryngology (“ENT”). The Company’s Navio® System incorporates patented technology to provide precise robotic control to surgeons via an intelligent, handheld, computer-assisted bone cutting tool. The Navio System provides the surgeon with a layer of safety and enhanced accuracy while performing bone shaping tasks through minimally invasive incisions. The Company’s STRIDE™ Unicondylar Knee system provides advanced implant features optimized for use with Navio. CRG Founded in 2003, CRG (previously known as Capital Royalty L.P.) is a healthcare-focused investment firm with $1.5 billion of assets under management that provides capital to healthcare companies primarily through structured debt and senior secured loans. CRG works across the spectrum of life science products and technologies and targets investment sizes ranging between $20 million and $200 million. The firm partners with commercial-stage healthcare companies to provide flexible financing solutions so they can achieve their growth objectives. CRG is headquartered in Houston, Texas with offices in Boulder, Colorado and New York City. For additional information, please visit crglp.com. Contacts Blue Belt Technologies, Inc. Adam Simone, 763-452-4917 asimone@bluebelttech.com or CRG Luke Duster, Managing Director, 713-209-7361 lduster@crglp.com Help employers find you! Check out all the jobs and post your resume.
适应症
-
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。